StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson Operational adjusted diluted EPS by Quarter

Operational (constant-currency) adjusted diluted EPS ($) ($)

QuarterlyAnnual

Johnson & Johnson Operational adjusted diluted EPS: $2.61 in Q3 2026, down 4.0% from a year earlier.

Latest, Q3 2026
2.61
Period ended Sep 30, 2026
Change on a year earlier
-4.0%
2.72 in Q3 2025
History
32 quarters
Since Q4 2017
Sources
32
Documents cited below

Where the Q3 2026 figure comes from

“|| Operational adjusted net earnings per share (Diluted) | $2.61 | $8.04”

Source: Form 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗

Reported in Form 8-K EX-99.2 Reconciliation of Non-GAAP Financial Measures.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOperational (constant-currency) adjusted diluted EPS ($) ($)Year on yearSource
Q3 2026Sep 30, 20262.61-4.0%Form 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗
Q2 2026Jun 28, 20262.86+5.5%Form 8-K (a2026q2exhibit991.htm, filed 2026-07-15) ↗
Q1 2026Mar 29, 20262.57-8.5%Form 8-K (a2026q1exhibit991.htm, filed 2026-04-14) ↗
Q4 2025Dec 28, 20252.35+14.6%Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
Q3 2025Sep 28, 20252.72+12.9%Form 8-K (a2025q3exhibit991.htm, filed 2025-10-14) ↗
Q2 2025Jun 29, 20252.71-3.9%Form 8-K (a2025q2exhibit991.htm, filed 2025-07-16) ↗
Q1 2025Mar 30, 20252.81+3.3%Form 8-K (a2025q1exhibit991.htm, filed 2025-04-15) ↗
Q4 2024Dec 29, 20242.05-10.1%Form 8-K (a2024q4exhibit991.htm, filed 2025-01-22) ↗
Q3 2024Sep 29, 20242.41-5.1%Form 8-K (a2024q3exhibit991.htm, filed 2024-10-15) ↗
Q2 2024Jun 30, 20242.82-0.7%Form 8-K (a2024q2exhibit991.htm, filed 2024-07-17) ↗
Q1 2024Mar 31, 20242.72-1.1%Form 8-K (a2024q1exhibit991.htm, filed 2024-04-16) ↗
Q4 2023Dec 31, 20232.28-7.3%Form 8-K (a2023q4exhibit991.htm, filed 2024-01-23) ↗
Q3 2023Oct 1, 20232.54-7.6%Form 8-K (a2023q3exhibit991.htm, filed 2023-10-17) ↗
Q2 2023Jul 2, 20232.84+3.3%Form 8-K (a2023q2exhibit991.htm, filed 2023-07-20) ↗
Q1 2023Apr 2, 20232.750.0%Form 8-K (a2023q1exhibit991.htm, filed 2023-04-18) ↗
Q4 2022Jan 1, 20232.46+12.8%Form 8-K (a2022q4exhibit991.htm, filed 2023-01-24) ↗

Cite this data

StockData. (2026). Johnson & Johnson Operational adjusted diluted EPS ($), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/ops-adj-eps-diluted

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.